Celyad Oncology SA (EBR:CYAD)
Belgium
· Delayed Price · Currency is EUR 0.4810
+0.0010 (0.21%)
Apr 25, 2025, 5:35 PM CET
Celyad Oncology Revenue
In the year 2024, Celyad Oncology had annual revenue of 186.00K EUR with 82.35% growth. Celyad Oncology had revenue of 172.00K in the half year ending December 31, 2024.
Revenue
186.00K
Revenue Growth
+82.35%
P/S Ratio
107.14
Revenue / Employee
10.33K
Employees
19
Market Cap
19.93M
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| argenx SE | 2.17B |
| UCB SA | 6.15B |
| Financière de Tubize | 13.26K |
| Fagron NV | 871.96M |
| Ion Beam Applications | 465.75M |
| Nyxoah | 4.52M |
| Hyloris Pharmaceuticals | 10.04M |
| Onward Medical | 1.70M |